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1. Introduction 
Brain cancer is a life threatening neurological disorder in which malignant cells, grow, 
proliferate and invade the original cerebral structures of the host, hampering seriously 
adequate brain function. Malignant cells generate eventually a dedifferentiated tumoral 
mass that interferes with vital brain functions as sensory and motor activations, memory 
and perception and neuroendocrine regulation, among others. The fully developed tumoral 
mass consumes a significant part of cerebral volume resulting in cerebral compression and 
serious neurological impairments, such as vision or hearing disturbances and eventually 
lethal cerebrovascular complications. Most brain tumors remain asymptomatic during early 
development, revealing their symptoms and lethal nature only at later stages. Therapy is 
facilitated many times by an early finding, a circumstance making the neuroimaging 
approaches particularly useful in the detection and handling of these lesions.  
In the last decades, Magnetic Resonance Imaging (MRI) approaches have evolved into the 
most powerful and versatile imaging tool for brain tumor diagnosis, prognosis, therapy 
evaluation, monitoring of disease progression and planning of neurosurgical strategies. MRI 
methods enable the non invasive assessment of glioma morphology and functionality 
providing a point of likeness into histopathological grading of the tumor and helping in this 
way a more successful patient management. This impressive evolution is based not only for 
the high resolution and quality of the anatomical images obtained, but on the additional 
possibilities to achieve quantitative functional information on tumoral physiopathology and 
its repercussions in the sensorial, motor and integrative functions through the brain. The use 
of conventional paramagnetic or superparamagnetic contrast media allows for the 
identification of areas with blood-brain barrier (BBB) disruption and the recent molecular 
imaging approaches enable researchers to visualize molecular events associated to tumor 
proliferation and invasion, bringing the potentials of diagnostic imaging to the cellular and 
molecular aspects of tumor biology. Moreover, functional MRI approaches as performed in 
the clinic are endowed with the potential to detect and characterize the earliest 
neoangiogenic, metabolic and hemodynamic alterations induced by the neoplasm. 
Several advanced magnetic resonance (MR) methodologies have been proposed in the last 
years to assess the functional competence in healthy and pathologic brain tissue. Diffusion and 
perfusion MRI are probably the two main approaches that have reached a relevant clinical role 
www.intechopen.com
 
Advances in the Biology, Imaging and Therapies for Glioblastoma 226 
in brain oncology, particularly in neovascular imaging (Calli, Kitis et al. 2006). The diffusion 
approaches investigate the thermally induced random molecular motions of water molecules 
in tissues. The perfusion phenomenon describes and quantifies the microvascular blood flow 
which feeds a volume element of an organ or tissue. At a first glance these two phenomena 
seem to be very different, however a closer look identifies they both concerned with 
underlying molecular motions. Moreover, the random distribution of capillaries in tissues 
such as brain, provides tissue perfusion with some of the characteristic features of diffusive 
motion. 
This chapter will summarize the arsenal of MRI approaches providing functional 
information on gliomas based on diffusion and perfusion MRI methods. We begin with a 
description of the pathological classification of gliomas and its implications for MRI 
diagnosis, continuing with the applications of diffusion weighted imaging (DWI), diffusion 
tensor imaging (DTI) and tractography to the characterization of these brain tumors. We 
conclude showing the MRI methodologies available for the evaluation of cerebral and 
tumoral perfusion, addressing the use of Dynamic Susceptibility Contrast (DSC), Dynamic 
Contrast Enhanced (DCE) MR images and Arterial Spin Labelling (ASL). Our review focuses 
mainly in the clinical applications of these methodologies, providing a brief introduction 
into the physical principles of each one. For interested readers, the following review articles 
provide more detailed descriptions of the corresponding physical principles of diffusion 
weighted (DW) MRI (Mori and Barker 1999), DTI (Basser and Jones 2002) and Tractography 
(Mori and van Zijl 2002) or the different approaches to investigate microvascular perfusion 
(Ostergaard 2005; Detre, Wang et al. 2009; Larsson, Courivaud et al. 2009).  
2. Histological classification of gliomas. Implications in MRI diagnosis 
Glioma is a non-specific term, broadly suggesting that the observed tumor originates from 
glial cells. These tumors account for more than 85% of primary brain neoplasms classified 
histologically, immunohistochemically and structurally as astrocytomas, 
ologodendrogliomas or oligoastrocytomas, depending on their morphological, 
immunochemical or molecular features. Gliomas are assigned a grade depending on their 
histolopathological properties (figure 1). The grade provides insight into the growth rate 
of the tumor. According to the classification of the World Health Organization (WHO), 
tumors in grade I depict the lowest malignancy, their cells look nearly normal and the 
tumor grows slowly. Grade II tumors are also slow growing, but show a slightly abnormal 
microscopic appearance. Grade III tumors are malignant by definition. Their cells look 
very different from the original neural cells and are actively proliferating. Grade IV is the 
most malignant and aggressive, defined by galloping genetic instability, complete 
morphological and metabolic reprogramming, fast and uncontrolled proliferation, intense 
resistance to apoptosis, diffuse infiltration, robust angiogenesis and propensity to 
necrosis. From this group Glioblastoma multiforme (GBM) is the most frequent, 
aggressive and lethal intracranial tumor, reaching approximately 50% of all astrocytomas 
(Furnari, Fenton et al. 2007). Despite decades of intensive research, high-grade gliomas 
(WHO grade III and IV) are currently estimated incurable with a poor or very poor 
survival, up to one year in glioblastoma and from two to three years in anaplastic 
astrocytomas (Reardon, Rich et al. 2006).  
The tumor grade determines the most appropriate chemotherapeutic or surgical treatment, 
but histology, requiring a tumor biopsy, remains currently the only method able to yield 
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unambiguously this information. In spite of this, many of the histopathological features of 
gliomas are amenable to MRI explorations. In particular, the growth rate and the 
appearance of necrotic zones may be followed by sequential morphological MRI 
examinations, the cellularity and tumor microstucture investigated by diffusion weighted 
MRI, the compression effects of the tumor on surrounding neuronal tracts of the white 
matter may be examined by MRI tractography from DTI approaches and the development 
of the neoangiogenic vasculature characterized by perfusion imaging. These properties 
entail the MRI method with unprecedented capabilities to asses non invasively glioma grade 
and its potential repercussions. In the following sections we shall provide a description of 
main physical principles underlying these methodologies and provide illustrative examples 
on their applications. 
 
 
(a)                                               (b)                                            (c) 
Fig. 1. Histopathological features from gliomas of increasing grade as revealed by 
haematoxylin/eosin  staning. (a) WHO grade II astrocitoma , (b) WHO grade III anaplastic 
astrocytoma and (c) WHO grade IV glioblastoma multiforme  
3. Diffusion magnetic resonance imaging 
The diffusion phenomenon describes quantitatively the random (Brownian) molecular motion 
translations of water molecules originating ultimately from thermal energy. In a tissue, like the 
brain, the mechanism of diffusion involves mainly the motion of water molecules on a scale of 
5 to 15 micrometers over the approximate 40 ms of measurement time. It is described by an 
Apparent Diffusion Coefficient (ADC), representing the average translational displacement of 
a water molecule during a time unit. The diffusion process has a vectorial nature, involving 
magnitude and direction. Its magnitude and direction in vivo depend on a variety of factors 
including permeability barriers and their spacing, microviscosity of the intracellular milieu, 
molecular obstructions to water displacements, duration of the diffusion measurement and, 
eventually the bulk flow within capillaries and water active transporters in tissue. These 
circumstances make the interpretation of diffusion measurements complex, but at the same 
time highly informative on all the aspects influencing it. 
In vivo Diffusion Weighted Imaging (DWI) provides images with an inherent contrast 
different from that obtained by conventional structural MR techniques. In this sense, DWI 
gives unique information about the microstructure and viability of brain tissue, with the signal 
intensity of the image depending on the average translational motion of water molecules, an 
aspect known to be appreciably modified in cerebral tumors (Schaefer, Grant et al. 2000).  
3.1 Apparent Diffusion Coefficient 
The first description of a diffusion study was provided by Stejskal and Tanner, who used a 
spin-echo acquisition protocol in which two gradient pulses equal in magnitude but 
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opposite in directions (figure 2) were intercalated before and after the 180 degrees 
refocusing pulse, thus allowing the measurement of molecular water motions in the 
direction of the applied gradient (Stejskal and Tanner 1965).  
 
 
Fig. 2. Diffusion Weighted MR Imaging. Left: The Stejskal-Tanner pulse sequence.  The 
basic spin-echo sequence is sensitized to diffusion using two phase gradients of duration 
, separated by the diffusional time , located symmetrically before and after the 180 
pulse. Center: Influence of cellularity on the translational diffusion measurements. Note 
that in the same time, a water molecule will move translationally a shorter path in an 
increased cellular density and molecularly more crowded medium. A representative 
image of the ADC measured in the normal rat brain (Pacheco-Torres, Calle et al.). 
Reproduced with permission 
Because of the same magnitude and the opposite directions of these two gradients, the MR 
signal of water molecules without net motion will be identical to its intensity as obtained 
without diffusion gradients in the same cerebral location. However, for locations showing 
net translational motion of water molecules in the direction of the applied gradient, the 
opposing effects of the two gradients will not be cancelled, and the resulting image will 
depict lower intensity in these regions. Signal intensity will be smaller, the faster the average 
movement of water molecules or the larger ADC. This leads to a DW image depicting 
hypointensity in the tissue voxels containing faster moving water molecules and 
hiperintensity in those with slower water displacements. 
Under these conditions, the MR signal loss is related to: (i) the diffusion coefficient of the 
water and (ii) the duration and strength of the magnetic field gradients used in the 
measurement. The following equation applies: 
 SI = SI0 x exp (-b x ADC) (1) 
where; SI0 represents the signal intensity for each pixel in the absence of  gradient pulses, 
b is an experimentally modifiable parameter including the duration , intensity and delay 
separation  of the applied magnetic field gradients and ADC is the apparent diffusion 
coefficient of the water in the investigated tissue voxel. Using images acquired with 
increasing b values and thus, increasingly sensitized to diffusion, a parametric map can be 
calculated by plotting for every pixel the linear relationship between the natural 
logarithm of the relative signal loss (SI/SI0) versus b. This affords the calculation of the 
corresponding ADC on a pixel-by-pixel base, representing then every pixel value in the 
resulting ADC map. 
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In vivo measurements of ADC in the human brain by using MRI are well documented both 
in physiological and physiopathological conditions (Le Bihan, Breton et al. 1986; Thomsen, 
Henriksen et al. 1987; Chien, Buxton et al. 1990; Hajnal, Doran et al. 1991; Schaefer, Grant et 
al. 2000). Regions of increased or decreased diffusion due to pathology can be clearly 
identified in a diffusion weighted MRI study by the corresponding changes in intensity, 
either in the diffusion weighted images or in fitted ADC maps.  
3.2 Diffusion weighted imaging of gliomas 
Although DWI studies were initially focused on stroke (Warach, Chien et al. 1992), multiple 
sclerosis (Larsson, Thomsen et al. 1992) and hydrocephalus (Gideon, Thomsen et al. 1994), 
an increasing number of diffusion studies on brain is being performed.  
In 1994 Tien et al. acquired diffusion images in patients with high-grade gliomas using Echo 
Planar Imaging (EPI) techniques to measure ADC along cephalocaudal axis, comparing the 
obtained results with those found by using conventional (SE) or fast spin-echo (FSE) MRI 
(Tien, Felsberg et al. 1994). The ADC images enabled these authors to differentiate various 
regions within the tumor, concluding that echo-plannar DWI appeared a more powerful 
tool in the characterization of brain neoplasm than conventional techniques.  
In 1995 Brunberg et al. reported their study performed with a motion-insensitive spin-echo 
sequence measuring ADC along three orthogonal axes (Brunberg, Chenevert et al. 1995). 
They aimed to determine if there was a relationship between water diffusion coefficients or 
its anisotropy in MR-defined regions of normal and abnormal parenchyma in patients with 
cerebral gliomas. They were able to distinguish between normal white matter, cystic or 
necrotic areas, regions of edema and solid enhancing tumor by comparing anisotropic ADC 
values in those regions.  
In 1997 Krabbe et al. measured ADC in different regions of patients with brain tumors 
(Krabbe, Gideon et al. 1997). They reported diffusion values in contrast-enhancing tumor, 
non-enhancing tumor, cyst or necrosis, edema and cerebro-spinal fluid (CSF) for malignant 
gliomas, low–grade gliomas, metastases, meningiomas and cerebral abscess. They found 
that mean ADC in contrast-enhancing tumor was significantly higher in metastases than in 
high-grade gliomas, while no significant differences were found between ADC in contrast-
enhancing tissue in meningiomas and metastases or high-grade gliomas. The highest ADC 
was always found in CSF. ADC in edema was higher than in contrast-enhancing tumor, and 
in edema around cerebral metastases was significantly higher than those around high-grade 
gliomas. These findings could help to distinguish on this basis high-grade gliomas and 
metastases prior to the surgery.  
After these initial reports, a large number of results have been published demonstrating the 
vast possibilities of diffusion MRI in brain oncology. These cover the applications of DWI 
from glioma characterization and evaluation to the identification of patients with poor 
treatment response or tumor recurrence (Provenzale, Mukundan et al. 2006; Hamstra, 
Rehemtulla et al. 2007; Hamstra, Galban et al. 2008). In addition, DWI imaging may allow 
the non invasive grading of tumor cellularity since cells constitute barriers that restrict 
microscopically the motion of the water molecules within the tissue. In this sense, the 
diffusion of water molecules across the tumor as compared to the diffusion in normal brain 
tissue is expected be different, depicting different diffusivity and ADC depending on the 
tumor cellularity and grade. As cells constitute a barrier to water motion, tumors with 
higher cellularity are expected to show lower ADC values than less cellularly crowded 
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tumors (Sugahara, Korogi et al. 1999; Gauvain, McKinstry et al. 2001). On the other hand, an 
increase in ADCs usually is correlated with decreased cellularity, revealing successful 
therapy and/or induced necrosis (Lyng, Haraldseth et al. 2000). Although some authors 
have reported lower diffusivity of water in high-grade than in low grade gliomas 
(Bulakbasi, Kocaoglu et al. 2003), it should be mentioned that there is a considerable overlap 
between ADCs in both types of neoplasm (Kono, Inoue et al. 2001). Even so, there is clearly 
an inverse correlation between tumor cellularity and ADC values measured in brain tumors 
allowing to distinguish these from other intracranial lesions. Figure 3 illustrates the 
important differences found in ADC of intratumoral and extratumoral  regions, in two 
different neoplasm types. Images (c) depict ADC maps in two patients with different brain 
tumor types. Upper panel shows a high average ADC in the patient with partially resected 
GBM, while in lower pannel reveals a low average ADC in a patient with a  primary CNS 
lymphoma. Regions of white matter edema distal to enhancing tumor margins usually show 
diffusion coefficient values significantly different from normal white and grey matter, and 
from areas of tumor cyst or necrosis, respectively. Notably, there are not appreciable 
differences between these ADCs from edema regions and those from enhancing tumor. 
 
(a) (b) (c)
Fig. 3. Upper panels: A patient with GBM and high ADC values. (a) Axial contrast-enhanced 
T1W image shows a mass; (b) T2W image shows lesion and edema; (c) ADC map shows that 
mean ADC in tumor is much higher than in normal brain. Lower panels: A patient with 
primary CNS lymphoma and low ADC values. (a) Axial contrast-enhanced T1W image 
shows non enhancing lesion; (b) T2W image shows signal intensity in tumor darker than 
gray matter; (c) ADC map shows mean ADC in tumor is lower than in normal tissue. 
(http://radiopaedia.org/encyclopaedia/cases) Reproduced with permission. 
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This is probably related with the fact that there is an increase in intracellular water in 
edematous white matter as well as within the tumor. Although this is true for almost all 
gliomas, its important to consider here, that interpretation of diffusion images and ADC 
values for diagnostic and prognostic purposes may be tumor type and individual-
dependent.  
3.3 Diffusion Tensor Imaging  
Water molecules are not able to diffuse with equal freedom in all directions through the 
brain, as surrounding cellular membranes and tissue structures limit to different extents 
their translational mobility in different directions. As a result, the ADC values measured in 
different directions are not equal and cerebral diffusion becomes anisotropic. This occurs 
mainly in white matter since molecular diffusion is relatively unrestricted along the 
trajectory of the neuronal axons and nerve fibres, but significantly more restricted in the 
perpendicular plane. The ADC in the grey matter, containing mainly neuronal bodies is 
more isotropic, with similar restrictions in all directions (Hajnal, Doran et al. 1991). This 
anisotropic behaviour of the molecular motions of water molecules in the brain can be 
observed by MRI obtaining images with the diffusion gradients applied in different spatial 
directions. The dominant direction and magnitude of water diffusion in every pixel is then 
obtained by calculating the resulting tensor from the ADC vectors measured in all 
investigated directions. This methodology is known as Diffusion Tensor Imaging (DTI), a 
method requiring the sampling of  the ADC in six or more directions (Nucifora, Verma et al. 
2007). This relatively complex mathematical modelling approach allows the preparation of 
three-dimensional ADC anisotropy maps, a very potent tool in the examination of the brain 
microstructure, inaccessible to other neuroimaging modalities. Using DTI sequences, it is 
possible to explore the integrity of white matter structures and detect abnormalities not 
visible in the conventional MRI acquisitions. DTI also allows to calculate tractography maps, 
revealing white matter fiber tracts, very useful to determine the infiltration or degeneration 
of the original fiber tracts by invading tumors (Mori and van Zijl 2002; Witwer, Moftakhar et 
al. 2002). 
3.3.1 Fractional Anisotropy and Mean Diffusivity  
Diffusion properties assessed by DTI, such as the fractional anisotropy (FA) and average of 
diffusion coefficient or mean diffusivity (MD), have become nowadays the most frequently 
used parametric images in neuro-oncology. Such images are correlated with cellular 
physiology and tissue microstructure, being extensively used to delineate glioma grades. 
MD measurements allow differentiation of necrotic areas within a high-grade gliomas and 
peritumoral edema from adjacent white matter; but they are not able to assess tumor 
infiltration adequately (Tropine, Vucurevic et al. 2004). On the other hand, FA values can be 
associated to functional tumoral characteristics, including WHO grade. So, combination of 
DTI related parameters in a multiparametric approach may facilitate glioma characterization 
and classification. In this respect, several reports aimed, at the precise elucidation of 
individual anisotropy patterns of brain water diffusivity which can reflect histopathological 
features used to graded gliomas (Jakab, Molnar et al.). Jakab et al. reported that these 
parameters can be used as indicators of glioma classification types and tumor 
physiopathology features like proliferation, metabolism or blood flow. These authors 
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proved a consistent relationship between DTI-related information and histopathological 
data obtained from biopsies.  
FA and MD are very sensitive indicators of white matter integrity also. Some clear examples 
of color-based images obtained from DTI acquisition are shown in figure 4 and 5, where not 
only edema region can be clearly distinguished from solid tumor by MD and FA color-based 
maps (figure 4), but also anisotropic directional maps depict those regions of fiber tract 
degeneration.  
The diffusion MRI study of a brain tumor patient may show a lack of a significant difference 
in mean diffusion anisotropy between cerebral cortex and solid tumor reflecting the 
disruption of myelinated fiber orientation by the pathology. In cystic or necrotic regions 
there is not anisotropy in diffusion. However, the mass effect of a tumor can induce a 
displacement or distortion of fiber tracts, by mechanical compression, yielding a decrease in 
mean ADC values and an increase in diffusion anisotropy relative to white matter in health 
hemisphere as it is shown in figure 5. Moreover, a significant difference in diffusion 
anisotropy appears between regions of white matter edema and tumor, enhancing or not. 
This difference is related to the existence of intact myelin membranes within the edema 
region and the loss of that integrity in areas of active tumor cell proliferation. This promises 
useful applications in diagnosis and preoperative planning since ADC values alone do not 
allow the distinction between enhancing central tumor and surrounding tissue.  
 
 
Fig. 4. Metastatic brain tumor. A: T1W image; B: T2W image; C and D show MD and FA 
overlay maps respectively, and mean values from peritumoral edema. (Lu, Ahn et al. 2003; 
Kinoshita, Yamada et al. 2005). Reproduced with permission 
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Fig. 5. T1W (upper) and relative anisotropy maps (lower). Each color indicates the principal 
eigenvector. Color intensity correlates with anisotropy grade. A: right frontal brain tumor; B: 
anaplastic ependymoma. In lower panels is clearly detected the loss of white matter 
integrity in both cases. (Lu, Ahn et al. 2003; Kinoshita, Yamada et al. 2005). Reproduced with 
permission 
3.3.2 Tractography 
Gliomas are infiltrating tumors in which the tumor cells may invade cerebral structures 
following the path of normal fiber tracts, making it difficult to differentiate tumoral from 
healthy tissue and detect the extension of white matter infiltration. Although several 
approaches from DTI have been reported to make the detection and reliable quantification 
of this diffuse tumor infiltration (Price, Burnet et al. 2003; Tropine, Vucurevic et al. 2004), 
this aspect still represents a very challenging question. One of the best developments to 
improve this situation is based in the visualization of diffusion tensor field by ellipsoids and 
colour coding of the main diffusion orientations (MDO) that allows the assessment of fibre 
bundles infiltration more reliably (Schluter, Stieltjes et al. 2005). The color maps and 
diffusion ellipsoids permit the identification of the particular fibre tracts bundles leading to 
the periphery of glioma by a reduced FA. Obviously, this approach is helping to improve 
therapeutic decisions and to minimize interventional risk. Additionally, it has been found 
that tumor recurrence has the tendency to occur along directions where the region of 
abnormal isotropic diffusion spreads beyond the region of abnormal anisotropic diffusion. 
On these grounds, it is eventually possible to predict regions of potential tumor infiltration 
and/or recidive by detecting abnormalities with high spatial resolution by using DTI.  An 
aspect of increasing interest is the development of new applications that allow obtaining not 
only presurgical but also postsurgical information related to the tumor affected tissue for a 
more accurate postoperative prognosis. 
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Fig. 6. MR images of a grade III glioma in the superior medial region of the left frontal lobe of a 
patient before (upper panels) and after (lower panels) surgery. A, D: T2W images, B, E: Gd-
enhanced T1W images, C, F: anisotropy weighted color maps allow differentiation of WM 
fiber tracts (green arrows) located in the tumor (white arrow) vicinity, PRE, POST: tractograms 
of the cortico-spinal tract. Yellow arrow signals deviation and deformation of the tract in the 
tumor proximity. (Lazar, Alexander et al. 2006). Reproduced with permission. 
As shown in figure 6, DTI is probably one of the most useful clinical applications in this 
direction, but one of the major obstacles for accurate reconstruction of white matter 
trajectories is the use of an adequate and suitable tracking algorithm. Simple tracking 
algorithms are not appropriate in anatomically complex fascicular pathways often leading to 
incorrect directional information. To solve this, sophisticated algorithms have been 
developed to improve reconstruction of fiber tracts in these complex areas. Even more, one 
of the main challenges in DTI fiber tractography studies is to have the skill to reconstruct 
white matter tracts related to a specific network. This becomes even more complicated in the 
presence of a tumor where functionally relevant regions are displaced or infiltrated in the 
surrounding tissue. That goal has encouraged some authors to develop strategies by 
combining functional MRI and DTI (fMRI-guided DTI) to define related structures based on 
functional anatomy for subsequent fiber tracking (Kleiser, Staempfli et al.). Obviously, the 
ability to extract the most useful information from DTI acquisition in diagnosis, prognosis 
and therapy validation of gliomas is an active and challenging area of interest in clinic and 
research.  
3.4 Assessment of treatment response with diffusion MRI 
Since ADC measurements are able to monitor cancer progression, they may be also sensitive 
to assess the effectiveness to therapy. An increase in the translational motion of water 
molecules is expected when there are physiological responses like a loss of membrane 
integrity, a decrease in cellularity, changes in cellular size, extracellular volume or 
membrane permeability (Hamstra, Rehemtulla et al. 2007). Even more, changes in ADC 
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have been reported to be dose dependent either on chemotherapy or radiotherapy in human 
brain tumors (Chenevert, Stegman et al. 2000). Concluding, by carrying out DWI studies and 
determining diffusion coefficients in glioma patients it is possible to distinguish different 
regions within the tumor, not accessible to conventional MRI techniques as well as to obtain 
an early prediction of the therapeutic efficacy. 
3.4.1 Functional Diffusion Maps  
More recently Functional Diffusion Maps (fDMs) were developed as a new application of 
DWI that can be used as a surrogate biomarker for brain tumor cellularity (Ellingson, 
Malkin et al. ; Moffat, Chenevert et al. 2005). fDMs obtained computationally allow 
establishing the correlation between water diffusivity and cellularity mainly to predict the 
effectiveness of tumor treatment on a voxel-by-voxel pixel analysis. These color based maps 
are obtained by comparing diffusion MR images at two time points, before and after 
therapy, to evaluate quantitatively the therapeutic-induced changes in ADC values of the 
tumor. These maps are depicted in three colors by segmenting the tumor in different regions 
depending on the magnitude and directions of the ADC changes, allowing the use of this 
computational analysis as a surrogate marker of the early tumor response to the treatment 
as depicted in figure 7. 
 
 
Fig. 7. fMD map involving coregistration of  images before and after the treatment. A three-
color overlay of postprocessed and analyzed maps show ADC values in the tumor that are 
unchanged (green), significantly increased (red), or significantly decreased (blue). These 
regions may be associated to unresponsive (green) or responsive (red, blue) regions. Data 
can be also represented in a scatter plot allowing quantitative assessment of ADCs changes 
(Moffat, Chenevert et al. 2006). Reproduced with permission. 
Some authors have concluded that fDMs as obtained from the analysis of longitudinal 
diffusion images appear as a potent tool to detect the therapeutic response of tumors 
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through the early detection of induced changes in their morphology (Moffat, Chenevert et 
al. 2006; Hamstra, Galban et al. 2008). A patient with a brain tumor that shows significant 
changes in its ADC values after treatment is supposed to be responsive to therapy. There 
is the hypothesis that the water liberated by cell necrosis as induced by therapy is the 
major mechanism for the induced ADC increase. So, the magnitude of change in tumor 
water diffusion as detected by MRI is related to the quantity of cells killed by therapy and 
hence, to its efficacy. These changes precede the volume changes in the tumor by several 
weeks, providing the main justification for DWI as an early predictor of treatment 
response in individual patients. Even more, no changes in diffusion coefficient indicate a 
therapeutically unresponsive tumor suggesting the prescription of an alternative 
therapeutic option.  
4. Perfusion magnetic resonance imaging 
Clinical perfusion MRI measurements are currently recognized as one of the most powerful 
tools to assess tumor vascularisation and responses to treatment through the evaluation of 
hemodynamic parameters. MRI approaches to measure perfusion, can be divided in two 
broad classes: those monitoring tissue signal changes using an exogenous relaxation contrast 
agent and those that use endogenous contrast. MR perfusion weighted imaging (PWI) 
allows for the noninvasive estimation of tumor grade preoperatively. This can help by 
directing the surgeon to biopsy the most aggressive portions of the neoplasm. In addition, 
perfusion MR provides an exquisite delineation of tumor margins and it is useful in the 
follow-up of brain tumor patients after treatment by allowing differentiation between 
radiation effects and recurrent tumor zones. Looking into the future, perfusion changes in 
brain tissues hold promise as surrogate markers of response to therapy in clinical trials of 
new antiangiogenic drugs. 
4.1 Physiological principles 
Histopathology as gold standard of tumor grading suffers of several limitations. Mainly, 
since just a few samples of tissue are obtained after biopsy, the most malignant regions may 
be missed. Neovascularization is one of the most important criteria of malignancy for 
glioma grading. Malignant astrocytomas recruit existing vessels in the microenvironment 
and lead to form new vascular networks to supply the nutrients and oxygen required for 
tumor growth and proliferation. Hence, it is widely accepted nowadays the importance of 
neoangiogenic pathways in the treatment of brain tumors, since tumor growth of a few 
millimeters, involves the development of sufficiently competent networks of vascular 
supplies (Folkman 1971). The net result is a complex system of abnormal vessels in the 
peritumoral space, characterized by abnormal blood flow and increased permeability to 
macromolecules, both factors being potentially used as biomarkers for the evaluation of 
tumor growth. Concomitantly, tumor vessels are more tortuous than the healthy brain, 
increasing the distance that blood must travel as it moves through the tumor. Perfusion 
abnormalities are therefore detected not only because the increased number of vessels in 
gliomas but also for the aberrant reaction of those vessels to the environment. Under these 
circumstances, disruption of angiogenesis plays an important role in established therapies of 
gliomas and in the development of new ones.  
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4.2 Techniques and methods 
Currently, there are three principal methods to measure hemodynamic perfusion 
parameters by using MRI: T2*-weighted DSC, ASL, and T1-weighted DCE acquisitions, 
respectively. Any of them involves the serial acquisition of images through the brain as 
magnetically labelled blood passes through it. The labelling procedure can be either based 
on an exogenous contrast material, typically a paramagnetic complex of gadolinimum 
(Gd), or on an endogenous magnetic label. Among them, T2*W dynamic susceptibility 
imaging is probably the most consolidated method to carry out MR perfusion in clinical 
environments not only in brain oncology but also in many other pathologies, mainly 
neurodegenerative diseases.  
4.2.1 Dynamic Susceptibility Contrast 
Nowadays, PWI employing DSC techniques is one of the most relevant procedures of 
functional MRI with an increasing number of clinical applications depending on software 
and hardware availability. DSC enhanced images allow for the evaluation of regional 
cerebral hemodynamics by analyzing changes in the intensity of the MR signal during the 
first pass (and often second) of a narrow and concentrated bolus of an exogenous CA, 
through the brain microvascular bed. This technique is often called bolus tracking and 
performs perfusion measurements employing very rapid imaging to capture the first pass 
of a rapidly injected intravenous contrast material (Rosen, Belliveau et al. 1990), exploiting 
the T2* susceptibility effects induced by the large local concentrations of the agent rather 
than the T1 shortening effects routinely used in contrast enhancement by conventional 
MRI. For accurate assessment of the circulation it is necessary to measure signal drop 
during the passage of the bolus with sequences endowed with high sensitivity and 
temporal resolution to the magnetic susceptibility changes occurring in the tissue during 
the pass of the  agent. One approach is to use EPI sequences enabling acquisition times of 
less than one second because the whole raw data set of an image is acquired after a single 
spin excitation. EPI is merely a read-out technique and can be combined with any 
technique of spin excitation (such as spin-echo or gradient echo). Due to the special 
readout scheme of EPI, and because major parts of k-space are affected by T2*, each EPI 
sequence is inherently T2* sensitive.  
In the brain, the first-pass extraction of the agent is zero when the blood-brain barrier (BBB) 
is intact, and the complete intravascular compartmentalization of the contrast creates strong, 
microscopic magnetic susceptibility gradients. These gradients cause dephasing of spins as 
the spins diffuse through the vessel. In general, pulse sequences without complete 
refocusing of static field inhomogeneities, as such gradient-echo (GE) will suffer a general 
signal loss due to the presence of microscopic field disturbances in the vessels. In terms of 
relaxivity, the shortening of T1 values affects only those protons near the unpaired electron 
clouds of the agent. This is a short-range effect. A distinct feature of the signal loss on T2*W 
images is that all protons near the CA are affected because the magnetic susceptibility effect 
spreads far beyond the immediate vicinity of the agent. This is considered a long-range 
effect. However, direct damage of the BBB in a tumor may cause a disruption in it and a 
leakage of contrast material, a circumstance indicating  that the factors responsible of the 
observed MR signal may be more complex.  
Experimentally, the contrast medium at high concentrations (narrow bolus), induces T2* 
shortening yielding firstly a signal loss, followed by a recovery as the agent is diluted in 
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tissues (i.e. healthy brain and tumor). So, the bolus can be tracked by the acquisition of a 
multislice series of T2*-sensitive images from which a graph of relative signal intensity 
against time can be composed showing the pixel by pixel effects of the CA transit in the 
image. There is an approximate linear relationship between tissue contrast agent 
concentration and change in T2* relaxation rate, and from the signal-time course, the 
concentration-time course of the contrast medium can be calculated with the expression: 
 Ct (t) = -1/TE [ln (St-S0)] (2) 
where Ct(t) is the concentration of the agent, St is the signal intensity at any time point, S0 is 
the basal signal intensity before the CA injection and TE the echo time. The concentration of 
contrast medium is linearly proportional to changes in rate of relaxation T2* (R2*). MR data 
can then be converted to R2* versus time evolution and these values can be fitted to a 
gamma variate function to correct for tracer recirculation. Assuming uniform arterial 
concentration profiles in all arterial inputs, relative cerebral blood volume (CBV) 
measurements are determined simply by integrating the area under the concentration time 
curve (figure 8). The peak integral (that is, the peak area under the curve) is taken as the 
relative CBV because this represents the volume of the effect. Other parameters of interest 
that can be measure in the curve are the time to peak (TTP) and the mean transit time 
(MTT), although the true MTT requires knowledge of the input function of the bolus. Figure 
8 depicts a simulation of the process.  
 
 
Fig. 8. Schematic behaviour of MR signal intensity as CA passes across the imagin plain in 
brain tissue 
In this way, post-processing of DSC enhanced MR images allows mapping CBV, cerebral 
blood flow (CBF) and MTT by using singular value decomposition and deconvolution 
(Ostergaard, Weisskoff et al. 1996). Regional CBV (rCBV) is defined as the total volume of 
blood traversing a given brain region, measured in milliliters of blood per gram of brain 
tissue (mL/g). Regional CBF (rCBF) is defined as the net volume of blood traversing a given 
brain region per unit time, measured in milliliters of blood per gram of brain tissue per 
minute (mL/g/min). The definition of regional MTT is more complex, but it can be 
described as the average amount of time it takes any water molecule or particle of CA to 
pass through the capillary bed, that is, to transverse between arterial inflow and venous 
outflow measured in seconds (s) (Covarrubias, Rosen et al. 2004). rMTT is equal to the ratio 
rCBV/rCBF and although CBV may be measured with other methods, MTT measurements 
necessarily rely on techniques sensitive to motion. 
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The higher vascularity of gliomas is usually assessed with PWI methods by measuring CBV 
in the tumor. A potential problem with the use of these techniques arises in regions of 
severe BBB disruptions as it happens in high-grade gliomas. The leakage of the contrast 
medium into the extravascular space during its first passage across the tumor capillary bed, 
increases signals above baseline due to the T1 shortening effect of the paramagnetic label 
used. Since the algorithm used to calculate CBV assumes a constant baseline, this signal 
increasing relies in an area above the concentration curve of CA versus time (left panel in 
figure 8) interpreted as a negative blood volume. This may yield a significant 
underestimation of CBV in gliomas (Aronen and Perkio 2002). Several improvements and 
multiple methods have been proposed to address this problem. One of the most extensively 
used in clinical settings is the presaturation of the extravascular extracellular space in the 
lesion with the preinjection of a low dose of CA (0.05 mmol/Kg) before starting perfusion 
MR acquisition with a normal dose of Gd (typically 0.2 mmol/Kg) intravenously injected at 
a high rate. Another approach consists in using a dysprosium (Dy) based contrast medium 
as a paramagnetic metal with stronger T2* effects than Gd but only slight capability in T1 
shortening (Vander Elst, Roch et al. 2002). A third option to reduce T1 effects goes through 
increasing the repetition time (TR) which reduces T1 effects but increases total acquisition 
time, thus reducing temporal resolution.  
 
 
Fig. 9. Correction of CBV underestimation in a high-grade glioma. A: T1W image (Gd 0.2 
mmol/Kg) shows an enhanced mass. B: Uncorrected CBV map shows low CBV within the 
lesion (black arrow). C: K2 first-pass permeability map shows increased permeability within 
the lesion, consistent with severe BBB breakdown. D: Corrected CBV map shows increased 
CBV within the lesion, as expected for a high-grade neoplasm (Covarrubias, Rosen et al. 
2004) Reproduced with permission. 
In addition, different computational approaches have been reported to avoid the CBV 
underestimation. In these methods, the images are mathematically corrected to account for 
extravasation of contrast material in regions of BBB breakdown under the premise that the 
observed Gd concentration can be divided in intra- and extravascular components (Aronen 
and Perkio 2002; Provenzale, Wang et al. 2002). With these methods, based in a two-
compartmental model, permeability can be estimated in regions of BBB disruption by 
generation of permeability (K2) maps that can be used to correct CBV as shown in figure 9.  
Although DSC has the potential to allow quantitative imaging of perfusion parameters at a 
high signal to noise ratio in a short scan time, quantification of MTT and CBF depends 
critically on accurate and precise measurement of an arterial input function (AIF). The AIF 
relies on the measurement of the signal response in the artery or arteries that feed the tissue 
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of interest. This is one factor that limits the ability to quantitate hemodynamic parameters 
from DSC studies. To measure AIF the imaging planes through the brain have to be chosen 
to contain a major intracranial artery feeding the tissue, typically one paraclinoid internal 
carotid artery or the middle cerebral artery (Covarrubias, Rosen et al. 2004). Then, a 
deconvolution algorithm is used to post-process the data and generate CBF and MTT maps. 
However, the absolute determination of hemodynamic parameters in not a crucial factor in 
grading human gliomas, the resulting ratios being equally valid for this purposes since they 
incorporate the measurement errors from both values.  
4.2.2 Dynamic Contrast Enhancement 
Dynamic contrast-enhanced T1W MRI (DCE-MRI) was developed in the 1990s for 
estimating BBB leakage (Tofts and Kermode 1991). It is entirely an approach to measure 
perfusion based on the T1 shortening caused by the infusion of a paramagnetic contrast 
media. The main objective of this technique is to measure tumor permeability by dynamic 
T1W imaging after the intravenous administration of a contrast medium. Typically, a single 
lower dose (0.1 mmol/Kg) and a lower rate than in DSC studies is injected to the patient 
followed by repetitive image acquisitions (every 15-30 seconds) through the tumor up to 5-
10 minutes rather than the first pass of the bolus. The method is focussed in allowing the 
leakage of the CA into the extravascular space and coming into equilibrium after several 
passes of the bolus through the microvascular tumor bed. 
In this sense, one of the main advantages of this method is that the extravasation of the 
contrast material through the BBB is not an artefact to be corrected. Dynamic T1W MRI 
acquisitions afford better visualization of tumoral heterogeneity in gliomas, improving the 
accuracy of the technique to detect tumor staging, tumor recurrence and follow-up response 
to therapies. 
Appropriate information from DCE images requires measuring the real T1 values of the 
tissues to take them as a baseline to perform an accurate pharmacokinetic analysis (Evelhoch 
1999). To get an optimal temporal resolution, three dimensional imaging schemes are 
typically used obtaining the arterial input function in the centre of the acquisition volumes. 
Hence, data acquisition parameters may influence data analysis and it is necessary to 
optimize them. Several post-processing methods have been developed to measure perfusion 
in gliomas using DCE approaches. M. Pauliah et al. described an improved procedure to 
perform cerebral perfusion maps using a spoiled gradient-recalled echo sequence and 
reporting not only morphological but also functional information in a single imaging 
acquisition (Pauliah, Saxena et al. 2007). Authors estimate a quantitative evaluation of both 
regional CBV and CBF using singular value decomposition (SVD)-based deconvolution 
techniques in which the concentration of contrast material passing through a given voxel 
can be expressed as a convolution of the AIF with the residue function tissue concentration 
(Ostergaard, Sorensen et al. 1996; Ostergaard, Weisskoff et al. 1996). Figure 10 shows one 
particular case from this study. 
In summary, DCE is a powerful tool capable of providing quantitative assessment of 
contrast uptake and characterization of microvascular structure in human gliomas. Even 
more, several comparative studies have reported that DCE MRI studies of tumour 
enhancement in glioma patients can be used for repeated studies with reasonable 
reproducibility (Jackson, Jayson et al. 2003).  
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Fig. 10. DCE images of a patient with histologycally proved astrocytoma grade III. A: Post 
Gd-injection T1W image. B: T2W image. D: T1W image (without CA administration). C: 
CBV and E: CBF maps generated 
4.2.3 Arterial Spin Labelling 
ASL perfusion imaging in the brain adds a new functional dimension to non invasive 
evaluation of the brain functionality with MRI. It is the only method that yields 
quantitative monitoring of cerebral perfusion over a period of several hours. Its non 
invasive nature allows an unlimited number of repeated measurements to be made with a 
high temporal resolution. ASL uses spatially selective inversion of the inflowing arterial 
blood magnetization as a method to label water molecules in blood. So, in a typical 
experiment the arterial blood is tagged and after a given delay, this tagged blood arrives 
at the imaging plane and an image is acquired. The MRI signal from inverted 
magnetization is made negative relative to uninverted one. When the labelled blood 
reaches the tissue, it attenuates the pre-existing signal from the image of that tissue. 
Therefore, a control measurement is required without tagging the arterial blood. The 
difference in signal intensity between both images is proportional to rCBF, through a 
calibration factor that depends primarily on global properties of blood. A schematic 
diagram of the process is shown in figure 11. This difference signal measures how much 
of the original arterial magnetization created by the inversion pulse has been delivered to 
the voxel and survives to the time of measurement. The magnetization difference (control 
minus taged) carried out into the voxel can be conceptually similar to a contrast material 
delivered to it by CBF. Under this assumption the same kinetic modelling arguments used 
in bolus tracking or DSC studies can be applied to ASL (Buxton, Frank et al. 1998). 
Nevertheless, several premises remain to be taken into account for an accurate 
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quantification of CBF by using ASL. The method necessarily has to: i) perform an accurate 
control measurement; ii ) create a well-defined tagged bolus of arterial blood, waiting 
sufficiently long for the bolus to be delivered to the imaging plane; and iii) account for 
relaxation of the magnetization label (Buxton 2005).  
 
 
 
 
Fig. 11. Fundamentals of the ASL method: Arterial blood is tagged by inverting the 
magnetization and, after a delay, it arrives to imaging plane decreasing its intensity in 
manner proportional to blood flow (taken from “ASL Perfusion Imaging: Concepts and 
Applications”, David C. Alsop., ISMRM-2006). Reproduced with permission. 
ASL is an attractive and ingenious method for clinical applications because it does not use 
an intravenous contrast agent, but merely a manipulation of the proton spin of water 
molecules within the vasculature, that has the potential to provide a robust estimation of 
CBF. Hence, the agent used in ASL for assessing perfusion is labelled water and not a 
paramagnetic or superparamagnetic contrast medium, potentially affecting the physical, 
chemical or physiological properties of the blood. Another advantage of this approach is 
that it is independent of tumor permeability, without the need to perform additional 
corrections in the post-processing of the data. The perfusion map obtained by difference of 
images is available just after acquisition with minimal post-processing, representing a clear 
benefit in routine clinical settings. On the other hand, ASL leads reliable absolute 
quantification of CBF that is not affected by BBB damages. 
The ASL methods apply a powerful magnetic gradient to invert the inflowing blood 
magnetization tagging it as it flows upstream. ASL techniques can be divided in two main 
classes, depending on how the tag is applied: continuous (CASL) or pulsed (PASL). In CASL 
the inflowing arterial blood is continuously labelled bellow the slab to be imaged until the 
tissue magnetization gets a steady state (Petersen, Zimine et al. 2006). In PASL the spin 
inversion is achieved using short inversion pulses in a thick slab located next to the slice of 
interest. This method is easier to implement and has less practical problems as compared 
with CASL (Petersen, Zimine et al. 2006). Interestingly, PASL does not suffer as many 
magnetization transfer effects as CASL methods, and the selective inversion applied is closer 
to the image slices yielding smaller signal attenuation because of the reduced transit delay 
and a better inversion efficiency. Even more, short inversion pulses minimize problems of 
energy deposition in humans at high fields.  
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ASL has been also used as a functional method to detect CBF changes in local CBF during 
task activation as a surrogate marker or neuronal activity. This can be very helpful in the 
assessment of gliomas. To investigate if ASL methodologies contribute measurements that 
can be used as reliable markers of tumor grade, several studies have compared the perfusion 
results obtained by MRI with histological data in glioma patients (Warmuth, Gunther et al. 
2003; Wolf, Wang et al. 2005). As perfusion MR leads to images of the entire neoplasm, these 
can help in characterizing the malignancy in gliomas overcoming some of the limitations of 
histopathology sampling. In this line, ASL perfusion images allow delineating tumor 
heterogeneity and this can be used to guide biopsy towards the most malignant region of 
the tumor. Some examples of perfusion maps obtained from ASL acquisitions in gliomas are 
shown in Figure 12. 
 
 
 
 
Fig. 12. Differential diagnosis of gliomas using ASL perfusion. A: Giant cells glioblastoma. B: 
Anaplastic astrocytomas. In both, left: post-contrast T1W; right: perfusion map from PASL 
(Tourdias, Rodrigo et al. 2008). Reproduced with permission. 
A close relationship has been established between ASL and bolus tracking methods in 
determining CBF in brain tumors, been both approaches able to differentiate between 
high-grade and low-grade gliomas. Probably, the main limitation of using ASL sequences 
is that they only allow for the calculation of CBF, whereas MR perfusion measurements 
based on the administration of a contrast material can provide additionally, CBV and 
MTT values by using DSC methods (T2*W based images), and permeability values by 
DCE sequences (T1W based images). This additional information may contribute 
appreciably to the characterization and grading of gliomas. On the other hand,  
comparative studies in glioma patients have shown that the ASL technique is more 
suitable than exogenous contrast-based perfusion analysis for assessing 
hypervascularized lesions, whereas it has a bigger error rate in the assessment of 
hypovascularized ones (Warmuth, Gunther et al. 2003). 
4.3 Tumor grading by perfusion MRI 
Current methods to grade gliomas have inherent limitations, the infiltrative proliferation 
as an intrinsic feature of the tumor becoming a significant problem. Conventional MR 
images with CA provide important information regarding Gd-based enhancement that is 
useful in characterizing tumor grade. The most malignant enhancing brain tumors include 
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high-grade gliomas, metastases, and lymphomas. These methods assign the most 
aggressive and malignant grade to the most enhanced tumors, but regarding the gliomas, 
this is not always reliable. A high-grade glioma may be often mistaken for a low-grade 
one when images show minimal edema, no gadolinium enhancement, no necrosis and no 
mass effect. Equally, low-grade gliomas can depict sometimes peritumoral edema, 
contrast enhancement, necrosis and mass effect leading to a high-grade false diagnosis 
(Law, Yang et al. 2003). In histopathology grading of gliomas, tumor cellularity and 
vascularity are the major factors to be taken into account. This information is accessible by 
the advanced functional MRI methodologies detailed in this chapter and can help in brain 
tumor grading.  As regarding perfusion-based maps it is widely accepted that high 
regional CBV is more likely in high-grade gliomas. This parameter can reflect tumor 
vascularity and be used as an indicator of histological grade. In fact, many groups have 
shown the ability of DSC MRI for estimating the histopathological glioma grade. Several 
studies reported rCBV values measured in a large number of brain tumor patients 
suggesting that this parameter can improve distinction between high-grade and low-
grade gliomas (Aronen, Gazit et al. 1994; Calli, Kitis et al. 2006) with a high true-positive 
rate and a very low false-negative rate. On the other hand, gliomas have a great 
histopathological variability and in this sense, perfusion maps allow also for the 
localization of foci with very high rCBV values within the tumor. PWI can thus be very 
helpful not only for a valuable preoperative grading, but also for guiding the surgeon to 
the most appropriate site to obtain a representative biopsy of the most malignant portion. 
Although CBV is the most commonly used hemodynamic parameter in glioma grading, the 
largest limitation, entailing special clinical relevance, is the lack of discrimination between 
anaplastic gliomas and glioblastoma multiforme, the two most aggressive tumors of the 
high-grade glioma group. Perfusion MRI studies report no significant difference in rCBV for 
both of them (Covarrubias, Rosen et al. 2004).  
4.4 Assessment of permeability with perfusion MRI 
A link between permeability, angiogenesis and malignancy in gliomas is normally assumed. 
Several perfusion MRI studies suggest a correlation between permeability and malignancy, 
but they do not establish a link between angiogenesis and permeability or angiogenesis and 
malignancy. What is widely accepted is that high permeability to macromolecules, due to 
the presence of endothelial gaps in tumor vasculature, is an important mediator of tumor 
growth and a pathognomonic feature for malignancy. Permeability studies are typically 
based in the determination of the transfer constant of contrast between the plasma and the 
extravascular extracellular space (Ktrans). Measurements of Ktrans are increasingly popular as 
a method for the quantification of contrast enhancement since they are designed to describe 
the distribution of contrast agent, free from scanning and machine dependant variables, 
which allow comparison of results from different studies and imaging centers. Nowadays, 
perfusion MRI parameters such as Ktrans and CBV can be directly correlated with 
histopathological changes in the brain. 
T1W dynamic contrast MRI is probably the preferred method to analyze vascular 
permeability in gliomas and for mapping tumor angiogenesis. There are important studies 
showing a strong correlation between tumor grade and microvascular permeability by using 
DCE imaging methods (Roberts, Roberts et al. 2002). The net result is that blood vessel 
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permeability in gliomas can be used as a non invasive surrogate marker able to provide 
information related to rate of angiogenesis in the tumor. High-grade gliomas depict high 
vascular permeability, a consequence of the massive BBB disruption leading to 
extravasation of contrast material into the extravascular space that becomes detectable in 
MR images. 
Although studies in humans have been typically carried out with DCE methods, it is also 
possible to perform and compare permeability measurements in grading gliomas employing 
T2* DSC techniques, within certain limitations (Provenzale, Wang et al. 2002). In this case, 
the Ktrans maps can be generated by employing a calculation that allows the separation of T1 
effects from the analysis. The advantage of using this method is that it is possible to obtain 
CBV and permeability maps from the same data set, providing simultaneously, two types of 
valuable information.  
4.5 Assessment of treatment response with perfusion MRI 
At present, the predominant method to assess tumor response to treatment is to measure the 
size of the lesion by using conventional, paramagnetically enhanced MRI. However, tumor 
size is not always specific of tumor behaviour and neoplastic features associated with 
aggressiveness of the tumor may vary without changes in the tumor size. On the other hand, 
since angiogenesis plays a critical role not only in the development of brain tumors but also 
in the malignant transformation, many of the novel therapies currently investigated are 
focused on antiangiogenic strategies. Monitoring the success of such therapeutic methods 
relies on the ability to quantify tumor vascularization through the measurements of 
hemodynamic parameters. It is widely accepted now that the use of quantitative 
measurements of tissue enhancement characteristics provides a more valuable indicator to 
monitor the therapeutic response of tumours to novel antiangiogenic drugs in the treatment 
of gliomas. For example, rCBV is supposed to reflect microvessel density, an early response 
in this parameter to antiangiogenic therapies should show a decrease, thus providing the 
potential to predict growth or regression.  
Figure 13 shows a clear example of this behaviour. While T1W images show tumor growth 
even 6 weeks after initiating the treatment, rCBV maps from PWI depict a much earlier drop 
in tumor perfusion. This demonstrates that tumor size and perfusion may lead opposite 
conclusions because they represent indeed, different tumor features. 
Because the increase in endothelial permeability is a primary effect of vascular endothelial 
growth factor (VEGF) and other angiogenic cytokines, changes in the capillary leakage of 
contrast media may offer a predictable response to anti-angiogenic therapies. Quantification 
of the enhancement effect is therefore a good candidate as a potential biomarker of drug 
activity. Changes in permeability occur rapidly in response to VEGF inhibitions, so 
assessment of these changes either by DSC or DCE can be used as a marker of 
antiangiogenic therapy responses. Although quantification of permeability would be an 
optimal strategy, this is in fact, extremely difficult to achieve. Along these lines, several 
pharmacokinetic models to analyze dynamic enhancement data have been developed to 
estimate Ktrans and used it as an therapeutic indicator (Jackson, Jayson et al. 2003). Now, it is 
accepted and recommended the use of perfusion MRI to monitor tumor angiogenesis and 
evaluate the response to antiangiogenic therapies, a subject that has gained considerable 
clinical and research efforts, even leading to published recommendations concerning this 
important capacity of MRI (Brasch, Li et al. 2000). 
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Fig. 13. Change in perfusion in a pathologically confirmed GMB case before (A) and after (B) 
the initiation of anti-angiogenic chemotherapy. Left images in both panels show contrast 
enhanced T1W images used to measure tumor volume (green). Right images depict CA 
leakage corrected rCBV maps showing tumor perfusion (red arrow) (Sawlani, Raizer et al.) 
Reproduced with permission. 
5. Concludig remarks and future perspectives  
In summary, we presented an overview of the fundamentals and clinical applications of 
advanced Magnetic Resonance Imaging protocols providing in situ information on water 
diffusion and blood perfusion in gliomas. These methodologies have shown considerable 
ability to provide functional information on the malignancy of these lesions as well as in its 
response to therapy. Together, they allow for a more adequate patient management based 
fully in non invasive non destructive examinations. These MRI approaches have been, 
however, applied independently in most cases. The future use of combinations of these two 
strategies may offer the possibility to compensate the limitations of one technology with the 
strengths of the other, still maintaining their non invasive character. In this sense, combined 
diffusion-perfusion methodologies may provide in the future significant advances, 
becoming even more effective in clinic for the diagnosis, prognosis and therapy assessment 
of gliomas.  
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